UK bolsters COVID-19 variant testing capabilities with £29.3m investment
New facility will fast-track vaccines for COVID-19 variants to “future-proof the country”
Read More
Tag: UK Vaccines Taskforce
GSK agrees to support manufacture of Novavax’ COVID-19 vaccine
British drugmaker will help to produce up to 60 million doses for use in the UK
Read More
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
- Gedeon Richter UK takes over UK rights to cariprazine
- Otsuka Pharmaceutical’s Dawnzera receives EC approval for hereditary angioedema prevention
